Prostate cancer testing has received significant attention lately as the industry seeks to find reliable ways of identifying the appropriate treatment strategy for patients diagnosed with such cancer. A new draft local coverage determination (LCD) proposed by Medicare Administrative Contractor Palmetto GBA notes that “[i]n 2014, nearly 233,000 men in the US will be diagnosed…

This content is for Paid Members only.
Login Register